article · CNS Drugs

TICA-CLOP STUDY: Ticagrelor Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke, a Randomized Controlled Multi-Center Trial

Sherihan Rezk Ahmed
Nevine El Nahas
Asmaa M. Hassan
Ahmed Elbassiouny
Mohamed Ismaiel
Doaa Mohamed
Ahmed Ahmed Mohamed Kamal Ebied
Hossam Mohamed Refat
Mohamed Fouad Elsayed Khalil
Tarek Omar
Mohamed Ahmed Almoataz
Ahmed Mohamed Ali Daabis
Mohamed G. Zeinhom

202411 citationsOpen accessKafr el-Sheikh University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

ClinicalTrials.gov identifier number NCT05553613.

Research topics

Antiplatelet Therapy and Cardiovascular Diseases
Acute Ischemic Stroke Management
Venous Thromboembolism Diagnosis and Management

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1007/s40263-024-01127-7

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.